Professor, Internal Medicine, Wayne State University School of Medicine

Infectious Disease

Dr. Glenn W. Kaatz, MD

Glenn Kaatz works in the field of Infectious Disease. He went to University of Michigan Medical School. Glenn Kaatz has written publications. He has 37 publications published with PubMed. The lastest publication is: 'Efavirenz-Associated Urinary Matrix Stone-A Rare Presentation.'

Publications

Efavirenz-Associated Urinary Matrix Stone-A Rare Presentation.
Mutations within the mepA Operator Affect Binding of the MepR Regulatory Protein and Its Induction by MepA Substrates in Staphylococcus aureus.
Analyses of Multidrug Efflux Pump-Like Proteins Encoded on the Staphylococcus aureus Chromosome.
Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline.
Structural mechanism of transcription regulation of the Staphylococcus aureus multidrug efflux operon mepRA by the MarR family repressor MepR.
Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureus.
Inhibition of drug efflux pumps in Staphylococcus aureus: current status of potentiating existing antibiotics.
Expression of multidrug resistance efflux pump genes in clinical and environmental isolates of Staphylococcus aureus.
Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus.
Evolution from a Natural Flavones Nucleus to Obtain 2-(4-Propoxyphenyl)quinoline Derivatives As Potent Inhibitors of the S. aureus NorA Efflux Pump.
Characterizing vancomycin resistant Enterococcus (VRE) strains with varying daptomycin (DAP) resistance developed in an in vitro Pharmacokinetic/Pharmacodynamic model.
Goldenseal (Hydrastis canadensis L.) Extracts Synergistically Enhance the Antibacterial Activity of Berberine via Efflux Pump Inhibition.
Discovery of Novel Inhibitors of the NorA Multidrug Transporter of Staphylococcus aureus.
Ethidium bromide MIC screening for enhanced efflux pump gene expression or efflux activity in Staphylococcus aureus.
From 6-aminoquinolone antibacterials to 6-amino-7-thiopyranopyridinylquinolone ethyl esters as inhibitors of Staphylococcus aureus multidrug efflux pumps.
Impact of inoculum size and heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) on vancomycin activity and emergence of VISA in an in vitro pharmacodyn...
From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
Inhibitors of bacterial multidrug efflux pumps from the resin glycosides of Ipomoea murucoides.
daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations.
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus.
Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents.
Fluoroquinolone resistance in Streptococcus pneumoniae: area under the concentration-time curve/MIC ratio and resistance development with gatifloxacin, gemifloxacin, l...
Antibacterials and modulators of bacterial resistance from the immature cones of Chamaecyparis lawsoniana.
Antimicrobial susceptibility and staphylococcal chromosomal cassette mec type in community- and hospital-associated methicillin-resistant Staphylococcus aureus.
Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus.
MepR, a repressor of the Staphylococcus aureus MATE family multidrug efflux pump MepA, is a substrate-responsive regulatory protein.
Polyacylated oligosaccharides from medicinal Mexican morning glory species as antibacterials and inhibitors of multidrug resistance in Staphylococcus aureus.
Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein.
Clinical isolates of Staphylococcus aureus from 1987 and 1989 demonstrating heterogeneous resistance to vancomycin and teicoplanin.
Effect of promoter region mutations and mgrA overexpression on transcription of norA, which encodes a Staphylococcus aureus multidrug efflux transporter.
Antibacterial and resistance modifying activity of Rosmarinus officinalis.
Serum bactericidal activity of the methoxyfluoroquinolones gatifloxacin and moxifloxacin against clinical isolates of Staphylococcus species: are the susceptibility br...
Activities of mutant prevention concentration-targeted moxifloxacin and levofloxacin against Streptococcus pneumoniae in an in vitro pharmacodynamic model.
Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus.
The Molecular Mechanisms of Allosteric Mutations Impairing MepR Repressor Function in Multidrug-Resistant Strains of Staphylococcus aureus.

Schools

University Of Michigan Medical School
University Mich Hosps

Doctors Specialties

Infectious Disease Medicine
Infectious Disease

Accepted Insurances

Education

University of Michigan Hospitals and Health Centers
University of Michigan Medical School

Hospital

DMC Harper University Hospital
John D. Dingell Veterans Affairs Medical Center

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Marcus J. Zervos, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Edemekong Bassey, MD This Doctor is OpenDoctor Recommended.
	Dr. Marwa Hammoud, MD
	Dr. Veronica T. Sanchez, MD
	Dr. Ernesto R. Montesino, MD This Doctor is OpenDoctor Recommended.
	Dr. Priscilla Rupali, MD
	Dr. Claudia P. Taramona Espinoza, MD
	Dr. Karam M. Obeid, MD This Doctor is OpenDoctor Recommended.